Welcome to the international HTA database

Showing [23712 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention of ventilator-associated pneumonia
2009	Blue Cross Blue Shield Association (BCBS)	Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Artificial liver support systems]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009	National Institute for Health and Care Excellence (NICE)	Alitretinoin for the treatment of severe chronic hand eczema. NICE technology appraisal guidance 177
2009	Penn Medicine Center for Evidence-based Practice (CEP)	Prevention and management of delirium
2009	HAYES, Inc.	Endoscopic retrograde cholangiopancreatography for the treatment of benign and malignant diseases of the pancreas and biliary tree
2009	Blue Cross Blue Shield Association (BCBS)	Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[AUDIT ONCOrisk: Quality of the information in the study about digestive oncological surgery results]
2009	VA Technology Assessment Program (VATAP)	Regionalization of surgical services
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Addendum to the Canadian Agency for Drugs and Technologies in Health guidelines for the economic evaluation of health technologies: specific guidance for oncology products
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 178
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Reuse of single use medical devices]
2009	Agency for Healthcare Research and Quality (AHRQ)	Horizon Scan: to what extent do changes in third-party payment affect clinical trials and the evidence base
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Prostacyclins (epoprostenol, iloprost, treprostinil and beraprost) for the management of primary pulmonary hypertension and pulmonary hypertension in collagen vascular disease
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to great saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Off-label use of bevacizumab: advanced adenocarcinoma of the pancreas
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Comparison of the effectiveness of slow-release dosage forms (depot) versus oral dosage forms of antipsychotics (typical and atypical), marketed in Catalonia, in patients with a diagnosis of schizophrenia]
2009	HAYES, Inc.	Nanoparticle-based cancer therapies: Albumin-bound paclitaxel
2009	VA Technology Assessment Program (VATAP)	Simulation training
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Tenofovir disoproxil for the treatment of chronic hepatitis B. NICE technology appraisal guidance 173
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Behavioural and skill-based early interventions in children with autism spectrum disorders]
2009	HAYES, Inc.	Endovenous laser therapy for varicose veins due to small saphenous vein reflux
2009	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Defibrillators in public places]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rituximab for the first-line treatment of chronic lymphocytic leukaemia. NICE technology appraisal guidance 174
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Development of a shared knowledge system for network assessment of technological innovation in medicine]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drugs for pulmonary arterial hypertension: a systematic review of the clinical-effectiveness of combination therapy
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. NICE technology appraisal guidance 170
2009	The Netherlands Organisation for Health Research and Development (ZonMw)	[Cost-effectiveness of the Australian medical sheepskin for the prevention of pressure ulcers in somatic nursing home clients]
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Effectiveness and cost-efficiency of phosphate binders in hemodialysis]
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	[The use of carmustine implants (Gliadel wafers) in patients with malignant glioma]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Eculizumab for the treatment of paroxysmal nocturnal haemoglobinuria]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of foot care instruments: a review of the guidelines
2009	National Institute for Health and Care Excellence (NICE)	Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma. NICE technology appraisal guidance 169
2009	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Assessments tools for risk prediction of cardiovascular diseases]
2009	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Curative treatment for esophageal cancer: systematic review of neoadjuvant therapy and chemoradiotherapy alone: summary]
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Effectiveness of the filum terminale section for the treatment of Chiari I malformation]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous immunoglobulin for chronic inflammatory demyelinating polyneuropathy: Clinical- and cost-effectiveness analyses
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009	National Institute for Health and Care Excellence (NICE)	Amantadine, oseltamivir and zanamivir for the treatment of influenza. NICE technology appraisal guidance 168
2009	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Hadrontherapy in the treatment of cancer]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009	National Institute for Health and Care Excellence (NICE)	Machine perfusion systems and cold static storage of kidneys from deceased donors. NICE technology appraisal guidance 165
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Chemo-nucleolysis and intradiscal electrotherapy. Systematic Review
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Health and health services use in immigrant and native population in Spain]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Foot care for patients with peripheral vascular disease: a review of the guidelines
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Percutaneous nucleotomy and percutaneous laser disk decompression. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Spiral Laminar Flow bypass graft for peripheral arterial disease
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Impact of clinical and health services research in advancing knowledge. Applied study to the CAHTA research calls]
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Home visits to patients with severe COPD - a health technology assessment]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Injection therapies and radiofrequency for the treatment of chronic back pain. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Pregabalin (Lyrica) for partial onset epilepsy - monotherapy
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Implementation and development of a treatment programme for peritoneal carcinomatosis in Catalonia. Indications and clinical results using Sugarbaker's technique]
2009	Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)	[Follow-Up for gynecological cancer]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Intraoperative radiotherapy for primary breast cancer. Systematic Review
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Classification of disease severity for neuro- and trauma rehabilitation. Part 2: international experiences with quality / performance assessments and reimbursement
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Dasatinib (Sprycel) for chronic myeloid leukaemia - first line
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2009	Committee for New Health Technology Assessment (CNHTA)	[ADAMTS 13 Activity]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Drug coated balloon catheter. Systematic Review
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Carisbamate for partial onset epilepsy
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Lower respiratory tract infections of a viral origin in the paediatric population: systematic review of Spanish literature]
2009	Committee for New Health Technology Assessment (CNHTA)	[Treatment of sepsis caused by G(-) bacteria through Toraymyxin]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Organic acid testing for autism: a review of the diagnostic accuracy
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Selective IgG Apheresis for ABO-incompatible kidney transplantation. Systematic Review
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Acquisition processes of certain product groups in hospitals - orthopaedic and cardiac implants.
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Everolimus for autosomal dominant polycystic kidney disease with renal impairment
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Miglustat (Zavesca) in the treatment of Niemann-Pick type C disease]
2009	Committee for New Health Technology Assessment (CNHTA)	[CYBB gene mutation analysis(sequencing)]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
2009	Andalusian Health Technology Assessment Area (AETSA)	[Endovascular treatment for thoracic aorta lesions]
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Image guided radiotherapy using cone-beam computed tomography. Systematic Review
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Haemocomplettan P alone or in combination with Fibrogammin P in acquired hypofibrinogenemia.
2009	NIHR Horizon Scanning Centre (NIHR HSC)	HandTutor for hand rehabilitation
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Overweight in the teenager population: quality of life, access to health care services and cost-effectiveness of interventions]
2009	HAYES, Inc.	Hunter Syndrome (Mucopolysaccharidosis Type II, MPS II)
2009	Committee for New Health Technology Assessment (CNHTA)	[PIGA (Phosphatidyl inositol glycan-Class A) mutation analysis]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intraperitoneal chemotherapy for ovarian cancer patients: a review of the clinical and cost-effectiveness
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pumpless extracorporeal lung assist (PECLA). Systematic Review
2009	HAYES, Inc.	Hyperbaric oxygen therapy for soft tissue radiation injuries
2009	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Stent-grafting of the ascending aorta. Systematic review - 1st update 2009
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Teduglutide for short bowel syndrome
2009	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Trabectedin (Yondelis) in the treatment of soft tissue sarcomas]
2009	Committee for New Health Technology Assessment (CNHTA)	[Auditory cortex stimulation]
2009	Norwegian Knowledge Centre for the Health Services (NOKC)	[The diagnostic accuracy of infrared tympanic, oral, axillary and temporal thermometry, compared with rectal readings when identifying fever in adult hospitalized patients]
2009	Canadian Agency for Drugs and Technologies in Health (CADTH)	Celecoxib for post-operative pain management: a review of the clinical benefit and harm